Lishan Su

11.6k total citations · 4 hit papers
184 papers, 8.8k citations indexed

About

Lishan Su is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Lishan Su has authored 184 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Immunology, 59 papers in Virology and 42 papers in Epidemiology. Recurrent topics in Lishan Su's work include Immune Cell Function and Interaction (71 papers), HIV Research and Treatment (59 papers) and T-cell and B-cell Immunology (38 papers). Lishan Su is often cited by papers focused on Immune Cell Function and Interaction (71 papers), HIV Research and Treatment (59 papers) and T-cell and B-cell Immunology (38 papers). Lishan Su collaborates with scholars based in United States, China and France. Lishan Su's co-authors include Kovalev Gi, Liguo Zhang, Chad Torrice, Matthew R. Ramsey, Norman E. Sharpless, Janakiraman Krishnamurthy, Khalid Al-Regaiey, Qi Jiang, Vernon M. Coffield and Yi Zhang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lishan Su

167 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ink4a/Arf expression is a biomarker of aging

2004 1.2k citations Chad Torrice, Matthew R. Ramsey et al. Journal of Clinical Investigation profile →
hDOT1L Links Histone Methylation to Leukemogenesis

2005 622 citations Qi Jiang, Lishan Su et al. profile →
Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

2012 516 citations Guangming Li, Haitao Guo et al. profile →
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease

2011 220 citations Michael L. Washburn, Moses T. Bility et al. Gastroenterology profile →

Peers

Countries citing papers authored by Lishan Su

Since Specialization

Citations

This map shows the geographic impact of Lishan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lishan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lishan Su more than expected).

Fields of papers citing papers by Lishan Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lishan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lishan Su. The network helps show where Lishan Su may publish in the future.

Co-authorship network of co-authors of Lishan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Lishan Su. A scholar is included among the top collaborators of Lishan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lishan Su. Lishan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8 ⁺ T cells during chronic HIV-1 infection 2025 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), Haisheng Yu, (unknown), Xiuting He, (unknown), James Ahodantin, (unknown), Jianwen Chen, Xiaoxuan Fan, (unknown), (unknown), R. Brad Jones, Shyam Kottilil, Poonam Mathur, Lishan Su	0
2	Generation and characterization of mature hepatocyte organoids for liver metabolic studies 2024 ·Journal of Cell Science ·Yuchen Liu, Yaxing Zhou, James Ahodantin, Jin Yu, (unknown), Zhonghe Sun, Xiaolin Wu, Lishan Su, Yingzi Yang	5
3	Modeling HBV Infection and Therapy in Immunodeficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver 2024 ·Methods in molecular biology ·James Ahodantin, Feng Li, Lishan Su	0
4	YAP mediates HIV-related liver fibrosis 2024 ·JHEP Reports ·(unknown), (unknown), James Ahodantin, (unknown), Yong-Tao Wang, Sanjoy K. Khan, Min Xu, Wenyu Lin, Nadia Alatrakchi, Lishan Su, Raymond T. Chung, Shadi Salloum	1
5	Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy 2023 ·Science Translational Medicine ·(unknown), (unknown), Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang, (unknown), Martin Devenport, Juanjuan Su, Musleh M. Muthana, Lishan Su, Yang Liu, Pan Zheng	10
6	Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming 2023 ·Cancer Immunology Research ·Shishuo Sun, (unknown), Mengmeng Lü, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Junnian Zheng, Lishan Su, Qing Zhang	12
7	Depletion of plasmacytoid dendritic cells and HIF-1α inhibition enhance immunotherapy against hepatocellular carcinoma 2023 ·The Journal of Immunology ·Degui Geng, Yin Wang, (unknown), James Ahodantin, Guangming Li, Lishan Su	1
8	TWO-SIGMA-G: a new competitive gene set testing framework for scRNA-seq data accounting for inter-gene and cell–cell correlation 2022 ·Briefings in Bioinformatics ·(unknown), Ming Hu, Liang Cheng, John A. Wrobel, Kirk C. Wilhelmsen, Lishan Su, (unknown), Di Wu	3
9	Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses 2022 ·JHEP Reports ·Yongzhen Liu, (unknown), (unknown), Yaron Bram, Vasuretha Chandar, (unknown), (unknown), Nicholas A. Crossland, Lishan Su, Robert E. Schwartz, Alexander Ploß	9
10	Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy 2022 ·JCI Insight ·James Ahodantin, Kouki Nio, (unknown), Xuguang Zhai, Eleanor Wilson, Shyamasundaran Kottilil, Liang Cheng, Guangming Li, Lishan Su	11
11	Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia 2021 ·Clinical Cancer Research ·Eben I. Lichtman, Hongwei Du, Peishun Shou, Feifei Song, Kyogo Suzuki, Sarah Ahn, Guangming Li, Soldano Ferrone, Lishan Su, Barbara Savoldo, Gianpietro Dotti	57
12	Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies 2021 ·Viruses ·Laura A. Novotny, J.G. Evans, Lishan Su, Haitao Guo, Eric G. Meissner	10
13	Streptavidin Promotes DNA Binding and Activation of cGAS to Enhance Innate Immunity 2020 ·iScience ·(unknown), Zhe Ma, (unknown), Joshua A. Boyer, Guoxin Ni, (unknown), Siyuan Su, Zhigang Zhang, Zhichuan Zhu, Jiayi Qian, Lishan Su, Qi Zhang, Blossom Damania, Pengda Liu	27
14	TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice 2020 ·PLoS Pathogens ·Véronique Godot, Colas Tchérakian, Laurine Gil, Iñaki Cervera-Marzal, Guangming Li, Liang Cheng, Nicolás Ortonne, Jean‐Daniel Lelièvre, Giuseppe Pantaleo, Craig Fenwick, Mireille Centlivre, Hugo Mouquet, Sylvain Cardinaud, Sandra Zurawski, Gérard Zurawski, Pierre Milpied, Lishan Su, Yves Lévy	18
15	Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection 2017 ·Gut ·Haijun Li, Naicui Zhai, Zhongfeng Wang, Hongxiao Song, Yang Yang, (unknown), Tianyang Li, Guangyi Wang, Junqi Niu, Ian Nicholas Crispe, Lishan Su, Zhengkun Tu	116
16	Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice 2015 ·mBio ·Christopher B. Whitehurst, Guangming Li, Stephanie A. Montgomery, Nathan D. Montgomery, Lishan Su, Joseph S. Pagano	38
17	A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease breakdown → 2011 ·Gastroenterology ·Michael L. Washburn, Moses T. Bility, Liguo Zhang, Kovalev Gi, Adam Buntzman, J. A. Frelinger, (unknown), Alexander Ploß, Charles M. Rice, Lishan Su	220
18	Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition 2010 ·Journal of Clinical Investigation ·Søren M. Johnson, Chad Torrice, (unknown), Kimberly B. Monahan, Qi Jiang, Yong Wang, Matthew R. Ramsey, Jian Jin, Kwok‐Kin Wong, Lishan Su, Daohong Zhou, Norman E. Sharpless	134
19	The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis 2005 ·The Journal of Experimental Medicine ·Xing Chang, Jian Gao, Qi Jiang, Jing Wen, (unknown), Lishan Su, Virginia Godfrey, Tao Zuo, Pan Zheng, Yang Liu	74
20	Modulation of HIV-1 Replication by a Novel RhoA Effector Activity 2000 ·The Journal of Immunology ·Liping Wang, Hangchun Zhang, Patricia A. Solski, Matthew J. Hart, Channing J. Der, Lishan Su	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact